| Obesity paradox in cardiovascular disease: where do we stand? S Carbone, JM Canada, HE Billingsley, MS Siddiqui, A Elagizi, CJ Lavie Vascular health and risk management, 89-100, 2019 | 402 | 2019 |
| IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2 BW Van Tassell, CR Trankle, JM Canada, S Carbone, L Buckley, ... Circulation: Heart Failure 11 (8), e005036, 2018 | 150 | 2018 |
| Lean mass abnormalities in heart failure: the role of sarcopenia, sarcopenic obesity, and cachexia S Carbone, HE Billingsley, P Rodriguez-Miguelez, DL Kirkman, R Garten, ... Current problems in cardiology 45 (11), 100417, 2020 | 133 | 2020 |
| The antioxidant potential of the Mediterranean diet in patients at high cardiovascular risk: an in-depth review of the PREDIMED HE Billingsley, S Carbone Nutrition & diabetes 8 (1), 13, 2018 | 112 | 2018 |
| Dietary fats and chronic noncommunicable diseases HE Billingsley, S Carbone, CJ Lavie Nutrients 10 (10), 1385, 2018 | 107 | 2018 |
| Dietary fat, sugar consumption, and cardiorespiratory fitness in patients with heart failure with preserved ejection fraction S Carbone, JM Canada, LF Buckley, CR Trankle, HE Billingsley, ... Basic to Translational Science 2 (5), 513-525, 2017 | 98 | 2017 |
| Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With … GF Wohlford, BW Van Tassell, HE Billingsley, D Kadariya, JM Canada, ... Journal of Cardiovascular Pharmacology 77 (1), 49, 2021 | 74 | 2021 |
| The role of diet and nutrition in heart failure: A state-of-the-art narrative review HE Billingsley, SL Hummel, S Carbone Progress in cardiovascular diseases 63 (5), 538-551, 2020 | 73 | 2020 |
| Low NT‐proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction LF Buckley, JM Canada, MG Del Buono, S Carbone, CR Trankle, ... ESC heart failure 5 (2), 372-378, 2018 | 53 | 2018 |
| Lifestyle interventions with a focus on nutritional strategies to increase cardiorespiratory fitness in chronic obstructive pulmonary disease, heart failure, obesity … HE Billingsley, P Rodriguez-Miguelez, MG Del Buono, A Abbate, CJ Lavie, ... Nutrients 11 (12), 2849, 2019 | 50 | 2019 |
| Peak oxygen consumption achieved at the end of cardiac rehabilitation predicts long-term survival in patients with coronary heart disease S Carbone, Y Kim, S Kachur, H Billingsley, J Kenyon, A De Schutter, ... European Heart Journal-Quality of Care and Clinical Outcomes 8 (3), 361-367, 2022 | 34 | 2022 |
| Relation of hepatic fibrosis in nonalcoholic fatty liver disease to left ventricular diastolic function and exercise tolerance JMN Canada, A Abbate, R Collen, H Billingsley, LF Buckley, S Carbone, ... The American journal of cardiology 123 (3), 466-473, 2019 | 30 | 2019 |
| Sarcopenic obesity in heart failure with preserved ejection fraction DL Kirkman, N Bohmke, HE Billingsley, S Carbone Frontiers in Endocrinology 11, 558271, 2020 | 29 | 2020 |
| Unsaturated fatty acids to improve cardiorespiratory fitness in patients with obesity and HFpEF: the UFA-preserved pilot study S Carbone, HE Billingsley, JM Canada, D Kadariya, H Medina de Chazal, ... JACC: Basic to Translational Science 4 (4), 563-565, 2019 | 28 | 2019 |
| The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA‐HF study S Carbone, HE Billingsley, JM Canada, E Bressi, B Rotelli, D Kadariya, ... Diabetes/metabolism research and reviews 36 (8), e3335, 2020 | 26 | 2020 |
| C-reactive protein and N-terminal pro-brain natriuretic peptide levels correlate with impaired cardiorespiratory fitness in patients with heart failure across a wide range of … J Van Wezenbeek, JM Canada, K Ravindra, S Carbone, CR Trankle, ... Frontiers in cardiovascular medicine 5, 178, 2018 | 24 | 2018 |
| Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics S Carbone, JM Canada, HE Billingsley, D Kadariya, DL Dixon, ... Diabetes, Obesity and Metabolism 20 (8), 2014-2018, 2018 | 24 | 2018 |
| Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post-Hoc Pooled Analysis of Two Clinical Trials LF Buckley, S Carbone, CR Trankle, JM Canada, CO Erdle, JA Regan, ... Journal of cardiovascular pharmacology 72 (1), 68, 2018 | 19 | 2018 |
| Sarcopenic obesity is associated with reduced cardiorespiratory fitness compared with nonsarcopenic obesity in patients with heart failure with reduced ejection fraction HE Billingsley, MG Del Buono, JM Canada, Y Kim, JI Damonte, ... Circulation: Heart Failure 15 (10), e009518, 2022 | 16 | 2022 |
| Prevalence and severity of nonalcoholic fatty liver disease among caregivers of patients with nonalcoholic fatty liver disease cirrhosis MS Siddiqui, S Carbone, R Vincent, S Patel, C Driscoll, FS Celi, ... Clinical Gastroenterology and Hepatology 17 (10), 2132-2133, 2019 | 16 | 2019 |
